Status:
UNKNOWN
Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
Lead Sponsor:
Peking University
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Invasive Fungal Infection
Aspergillosis
Eligibility:
All Genders
Brief Summary
The purpose of this study is to assess the cut-off value of GM/G test in Chinese patients after hematopoietic stem cell transplantation, and evaluate GM/G test and real-time PCR for diagnosis of IFI i...
Detailed Description
Invasive fungal infection is one of the major complications of HSCT recipients, and the incidence is increased rapidly in recent years. IFI also commonly occurs in Chinese HSCT recipients, and there i...
Eligibility Criteria
Inclusion
- Persistent fever(\>38.0℃) after three days broad-spectrum anti-bacteria or virus therapy
- Chinese patients after hematopoietic stem cell transplantation
Exclusion
- Severe hemolysis patients
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
End Date :
December 1 2008
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00460330
Start Date
April 1 2007
End Date
December 1 2008
Last Update
April 13 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Hematology, the People's Hospital, Peking University
Beijing, China, 100044